Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sevoflurane for Chronic Venous Ulcers
NCT05303805Phase 4Recruiting
- Sponsor
- Charles University
- Start
- May 2022
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of sevoflurane in leg ulcer (2 arms), sponsored by Charles University. Primary endpoint: Pain intensity at 5 days. Started May 2022; status: recruiting.
02
Drugs
sevoflurane
03
Conditions
leg ulcer
Beyond the preview
Go deeper on NCT05303805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05303805.